Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients
Conditions
- ST-elevation Myocardial Infarction (STEMI)
- Acute Myocardial Infarction (AMI)
- Coronary Artery Disease
Interventions
- DRUG: empagliflozin
- DRUG: Placebo
Sponsor
Rehman Medical Institute - RMI
Collaborators